Privia Health Group, Inc. (PRVA) — Analyst outlook / Analyst consensus target is. Based on 22 analyst ratings, the consensus is bullish — 20 Buy, 2 Hold.
The consensus price target is $31.00 (low: $22.00, high: $36.00), representing an upside of 34.1% from the current price $23.12.
Analysts estimate Earnings Per Share (EPS) of $0.13 and revenue of $1.70B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $0.12 vs est $0.13 (missed -8.1%). 2025: actual $0.19 vs est $0.13 (beat +44.3%). Analyst accuracy: 80%.
PRVA Stock — 12-Month Price Forecast
$31.00
▲ +34.08% Upside
Average Price Target
Based on 22 Wall Street analysts offering 12-month price targets for Privia Health Group, Inc., the average price target is $31.00, with a high forecast of $36.00, and a low forecast of $22.00.
The average price target represents a +34.08% change from the last price of $23.12.
Highest Price Target
$36.00
Average Price Target
$31.00
Lowest Price Target
$22.00
PRVA Analyst Ratings
Buy
Based on 22 analysts giving stock ratings to Privia Health Group, Inc. in the past 3 months
EPS Estimates — PRVA
80%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.12
vs Est $0.13
▼ 8.8% off
2025
Actual $0.19
vs Est $0.13
▲ 30.7% off
Profitability Outlook
Company is profitable but with thin earnings per share. EPS trend is improving.
Revenue Estimates — PRVA
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.736B
vs Est $1.697B
▲ 2.2% off
2025
Actual $2.123B
vs Est $2.098B
▲ 1.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
